These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26301498)

  • 1. Empiric Monotherapy Versus Combination Therapy for Enterobacteriaceae Bacteremia in Children.
    Berkowitz NM; Spaeder MC; DeBiasi RL; Campos J; Singh N
    Pediatr Infect Dis J; 2015 Nov; 34(11):1203-6. PubMed ID: 26301498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
    Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
    Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric combination therapy for gram-negative bacteremia.
    Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
    Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region.
    Chaubey VP; Pitout JD; Dalton B; Gregson DB; Ross T; Laupland KB
    BMC Infect Dis; 2014 Dec; 14():647. PubMed ID: 25494640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children.
    Ivády B; Kenesei É; Tóth-Heyn P; Kertész G; Tárkányi K; Kassa C; Ujhelyi E; Mikos B; Sápi E; Varga-Heier K; Guóth G; Szabó D
    Infection; 2016 Jun; 44(3):309-21. PubMed ID: 26546372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of extended-spectrum β-lactamase producing Enterobacter spp. in patients with bacteremia in a tertiary hospital in southern Brazil.
    Nogueira Kda S; Paganini MC; Conte A; Cogo LL; Taborda de Messias Reason I; da Silva MJ; Dalla-Costa LM
    Enferm Infecc Microbiol Clin; 2014 Feb; 32(2):87-92. PubMed ID: 23587705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms.
    Martínez JA; Cobos-Trigueros N; Soriano A; Almela M; Ortega M; Marco F; Pitart C; Sterzik H; Lopez J; Mensa J
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3590-6. PubMed ID: 20585123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
    Huang SS; Lee MH; Leu HS
    J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
    Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
    Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of children with enterobacteriaceae bacteremia with reduced susceptibility to ceftriaxone: do the revised breakpoints translate to improved patient outcomes?
    Tamma PD; Wu H; Gerber JS; Hsu AJ; Tekle T; Carroll KC; Cosgrove SE
    Pediatr Infect Dis J; 2013 Sep; 32(9):965-9. PubMed ID: 23470679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia.
    Ambroggio L; Taylor JA; Tabb LP; Newschaffer CJ; Evans AA; Shah SS
    J Pediatr; 2012 Dec; 161(6):1097-103. PubMed ID: 22901738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
    Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemia.
    Marimuthu K; Ng TM; Teng C; Lim TP; Koh TH; Tan TY; Krishnan PU; Lye D
    J Infect; 2013 Mar; 66(3):294-6. PubMed ID: 23201151
    [No Abstract]   [Full Text] [Related]  

  • 16. Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.
    Turnidge JD; Gottlieb T; Mitchell DH; Coombs GW; Daly DA; Bell JM;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E327-33. PubMed ID: 25631595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Community- and non-community-acquired bacteremia: correlation between empiric antimicrobial therapy and susceptibility of micro-organisms isolated during 2007 in the Ile-de-France microbiologists network].
    Porcheret H; Barraud D; Bingen M; Rabenja T; Costa Y; Estève V; Faibis F; Demachy MC; Scanvic A; Vallée E; Péan Y
    Pathol Biol (Paris); 2010 Apr; 58(2):e7-e14. PubMed ID: 19875246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
    Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES
    JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-treatment of carbapenemase-producing Enterobacteriaceae.
    Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
    Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins.
    de Oliveira MS; de Assis DB; Freire MP; Boas do Prado GV; Machado AS; Abdala E; Pierrotti LC; Mangini C; Campos L; Caiaffa Filho HH; Levin AS
    Clin Microbiol Infect; 2015 Feb; 21(2):179.e1-7. PubMed ID: 25599940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.